Profile
George G.
White is currently the Director at National Health Foundation since 2017.
He was previously a Director at Assurex Health, Inc.
George G. White active positions
| Companies | Position | Start |
|---|---|---|
| National Health Foundation | Director/Board Member | 01/03/2017 |
Former positions of George G. White
| Companies | Position | End |
|---|---|---|
Assurex Health, Inc.
 Assurex Health, Inc. Pharmaceuticals: MajorHealth Technology AssureRx Health, Inc. operates as a personalized medicine company that develops genetic tests. It specializes in pharmacogenomics, a study of the genetic factors that influence an individual’s response to drug treatments, as well as evidence-based medicine and clinical pharmacology. The firm offers GeneSight, a genetic test that helps healthcare providers to take a personalized approach for prescribing medicine for patients; GeneSight Psychotropic, a test that analyzes genes that affects a patient’s response to antidepressant and antipsychotic medications; and GeneSight Analgesic, a test that analyzes how genes affect the way the body respond to medicines prescribed to treat acute or chronic pain. The company was founded by Donald R. Wright Jr. in 2006 and is headquartered in Mason, OH. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Assurex Health, Inc.
Assurex Health, Inc. Pharmaceuticals: MajorHealth Technology AssureRx Health, Inc. operates as a personalized medicine company that develops genetic tests. It specializes in pharmacogenomics, a study of the genetic factors that influence an individual’s response to drug treatments, as well as evidence-based medicine and clinical pharmacology. The firm offers GeneSight, a genetic test that helps healthcare providers to take a personalized approach for prescribing medicine for patients; GeneSight Psychotropic, a test that analyzes genes that affects a patient’s response to antidepressant and antipsychotic medications; and GeneSight Analgesic, a test that analyzes how genes affect the way the body respond to medicines prescribed to treat acute or chronic pain. The company was founded by Donald R. Wright Jr. in 2006 and is headquartered in Mason, OH. | Health Technology |
| National Health Foundation |
- Stock Market
- Insiders
- George G. White
